CLINICAL_TRIALS
trial_result
· 2015-10-12
Clinical Trial Update: Study of Pulmozyme to Treat Severe Asthma Episodes [Phase 2]
Summary
A Phase 2 clinical trial evaluating Pulmozyme (dornase alfa) for treating severe asthma episodes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwell Health | Conditions: Asthma | Phase 2 | Status: COMPLETED